Claris Lifesciences Ltd Half Yearly Results

Gross Sales

7.44

7.29

3.15

363.83

375.04

Excise Duty

0

0

0

0

0

Net Sales

7.44

7.29

3.15

363.83

375.04

Other Operating Income

0

0

0

6.02

9.33

Other Income

1,902.6

93.9

96.1

11.31

29.16

Total Income

1,910.05

101.18

99.25

381.15

413.53

Total Expenditure

37.93

60.01

43.41

321.1

325.38

PBIDT

1,872.12

41.17

55.84

60.05

88.14

Interest

1.66

-1.1

5.09

21.25

21.52

PBDT

1,870.45

42.28

50.75

38.8

66.62

Depreciation

2.21

2.33

1.64

28.49

14.42

Minority Interest Before NP

0

0

0

0

0

Tax

0

0.71

0

11.45

16.98

Deferred Tax

8.76

-16.3

-5.27

0

0

Reported Profit After Tax

1,859.48

55.54

54.39

-1.14

35.22

Minority Interest After NP

0

0

0

0

0

Net Profit after Minority Interest

1,859.48

55.54

54.39

-89.28

31.24

Extra-ordinary Items

0

0

0

-37.83

0

Adjusted Profit After Extra-ordinary item

1,859.48

55.54

54.39

-51.45

31.24

EPS (Unit Curr.)

340.77

10.18

9.97

0

5.73

Book Value (Unit Curr.)

0

0

0

0

0

Dividend (%)

0

0

0

0

0

Equity

54.57

54.57

54.57

54.57

54.57

Public Shareholding (Number)

0

0

0

0

2,12,85,801

Public Shareholding (%)

0

0

0

0

39.01

Pledged/Encumbered - No. of Shares

0

0

0

0

59,28,384

Pledged/Encumbered - % in Total Promoters Holding

0

0

0

0

17.81

Pledged/Encumbered - % in Total Equity

0

0

0

0

10.86

Non Encumbered - No. of Shares

0

0

0

0

2,73,53,580

Non Encumbered - % in Total Promoters Holding

0

0

0

0

82.19

Non Encumbered - % in Total Equity

0

0

0

0

50.13

PBIDTM(%)

25,162.9

564.74

1,772.69

16.5

23.5

PBDTM(%)

-

-

-

-

-

PATM(%)

24,993.01

761.86

1,726.66

-0.31

9.39